Andre T, Elez E, Lenz HJ, Jensen LH, et al. Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial. Lancet 2025 Jan 23:S0140-6736(24)02848-4. doi: 10.1016/S0140-6736(24)02848.
PMID: 39874977